EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205 – Abstract | Investigative Urology | UroToday

Genomic Analysis of Circulating Tumor DNA in Plasma of mCRPC Patients Treated with Abiraterone Acetate and Enzalutamide, prostate cancer, zytiga, xtandi (EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and…

Source: urotoday.com

See on Scoop.itProstate Cancer: Psycho-Social Aspects to Disease Pathway Management